Certified by Founder Lodge 
                                        
                                        Tome Biosciences
 
                                                 United States  -  Watertown, Massachusetts 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $213,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2021
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Tome Biosciences is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the genome with site-specific p
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| December, 14 ,2023 | Series B | $213,000,000 | 
                                                
 ARCH Venture Partners
                                                                                
 Polaris Partners
                                                                                
 Alexandria Real Estate Equities, Inc.
                                                                                
 a16z Bio + Health
                                                                                
 Longwood Fund
                                                                                
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
 
                                            
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)